泰凌医药(01011)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01011 泰凌医药

休市中 04-30 10:17:29

0.650

-0.020

-2.99%

最高0.650	最低0.650	成交量1.78万
今开0.650	昨收0.670	日振幅0.00%
总市值6.17亿	流通市值6.17亿	总股本9.49亿
成交额1.12万	换手率0.00%	流通股本9.49亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01011","market":"HK","secType":"STK","nameCN":"泰凌医药","latestPrice":0.65,"timestamp":1777515449957,"preClose":0.67,"halted":0,"volume":17750,"delay":0,"changeRate":-0.02985074626865674,"floatShares":949000000,"shares":949000000,"eps":-0.04840332667356149,"marketStatus":"休市中","change":-0.02,"latestTime":"04-30 10:17:29","open":0.65,"high":0.65,"low":0.65,"amount":11227,"amplitude":0,"askPrice":0.67,"askSize":10000,"bidPrice":0.65,"bidSize":70000,"shortable":0,"etf":0,"ttmEps":-0.03440179578789018,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1303228800000,"exchange":"SEHK","adjPreClose":0.67,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.21005917164735127,"lotSize":10000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01011/wiki","defaultTab":"wiki","newsList":[{"id":"1162852893","title":"泰凌医药2025年度业绩：收入降幅显著、亏损显著收窄，持续推进AI医疗与传统业务融合","url":"https://stock-news.laohu8.com/highlight/detail?id=1162852893","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162852893?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:27","pubTimestamp":1777544840,"startTime":"0","endTime":"0","summary":"截至2025年12月31日止年度，泰凌医药录得收益约人民币2,416万元，服务成本约人民币1,455万元，同比降幅更为明显，使毛利升至约人民币961万元，同比增长82.7%。年内亏损则由上年度的约人民币5,348万元缩减至约人民币2,626万元，幅度收窄近五成。审计报告显示，鉴于亏损与净负债规模较大，集团的持续经营能力存在不确定性。总体而言，泰凌医药于2025年度收入虽有明显回落，但亏损幅度显著收窄，并在智慧健康与AI融合方向上加大布局力度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"泰凌医药2025年度业绩：收入降幅显著、亏损显著收窄，持续推进AI医疗与传统业务融合","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165069040","title":"泰凌医药授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1165069040","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165069040?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:26","pubTimestamp":1777544806,"startTime":"0","endTime":"0","summary":"泰凌医药公告显示，公司获股东大会提案授权，拟回购不超过截至决议通过当日已发行股本总数10%的股份。根据公告，公司当前已发行股本为948,997,694股，此次购回上限约为94,899,769股。公告附带近12个月的股份交易价格，最高价约为1.35港元，最低价约为0.22港元。公司方面强调，将综合考虑财务状况及市场情况审慎行使回购授权。根据董事会意见，回购计划仍需在2026年6月4日召开的股东周年大会上正式审议和表决，并在授权期限内按实际情况执行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"泰凌医药授予董事股份购回授权，规模达已发行股本一成","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627314434","title":"泰凌医药(01011)：楼勇斌获委任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2627314434","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627314434?lang=zh_cn&edition=full","pubTime":"2026-04-13 18:31","pubTimestamp":1776076291,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰凌医药(01011)发布公告，楼勇斌先生已获委任为公司非执行董事，自2026年4月13日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427817.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143006625","title":"泰凌医药3月新增发行约2.75亿股 普通股总数增至约9.49亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143006625","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143006625?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:47","pubTimestamp":1775116040,"startTime":"0","endTime":"0","summary":"泰凌医药于2026年4月2日发布截至2026年3月31日的股份变动月报表。报告期内，公司普通股由原先的674,246,015股增加至948,997,694股，增幅为274,751,679股。该增发所涉普通股以每股港币0.45的价格发行，于2026年3月25日完成。公司注册股本方面，普通股注册股份数为62,592,500,000股，优先股注册股份数为32,500,000股，本报告期未发生变化，公司注册股本总额维持在美元50,100。截至本月末，公司普通股总数由此增至948,997,694股，且公司确认已符合香港联交所相应的公众持股量要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624053500","title":"泰凌医药(01011)发布年度业绩，股东应占亏损2604.1万元 同比减少51.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624053500","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624053500?lang=zh_cn&edition=full","pubTime":"2026-04-01 00:05","pubTimestamp":1774973136,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰凌医药(01011)发布截至2025年12月31日止年度业绩，该集团取得收益2415.8万元，同比减少36.36%;公司拥有人应占亏损2604.1万元，同比减少51.2%;每股亏损4.22分。公告称，本集团的传统业务于回顾年度内继续缩减，而医疗科技相关业务于2025年仍处于资产准备及合规整合阶段，尚未形成收入贡献。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01011","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623865342","title":"泰凌医药(01011)预计2025年度亏损净额约1090万元至1590万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623865342","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623865342?lang=zh_cn&edition=full","pubTime":"2026-03-30 23:42","pubTimestamp":1774885349,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰凌医药(01011)发布公告，经与公司核数师在审计过程中进一步讨论，并根据核数师截至本公告日期已完成的审计工作，董事会谨此进一步知会股东及潜在投资者，集团预期就发行新股份以偿付债务确认一次性非现金收益约1540万港元(相当于约人民币1410万元)。因此，集团截至2025年12月31日止年度的预期亏损将较先前公告所披露者进一步减少约1540万港元(相当于约人民币1410万元)，而经修订预期亏损净额将介于约人民币1090万元至1590万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"泰凌医药(01011)预计2025年度亏损净额约1090万元至1590万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157487992","title":"泰凌医药：预计2025年度亏损净额降至约人民币10.9百万元至15.9百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157487992","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157487992?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:23","pubTimestamp":1774880588,"startTime":"0","endTime":"0","summary":"泰凌医药3月30日晚间发布盈利警告补充公告称，经与核数师进一步沟通，并基于目前已完成的审计工作，公司预计将因以新发行股份偿债确认一次性非现金收益约1,540万港元。受此影响，集团截至2025年12月31日止年度的预期亏损将进一步减少约1,540万港元，对应人民币约1,410万元。调整后，全年净亏损预计介乎人民币10.9百万元至15.9百万元。公司董事会已订于2026年3月31日召开会议，审议并批准截至2025年12月31日止年度经审计业绩。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122783989","title":"泰凌医药年度预期亏损较先前指引再减1540万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122783989","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122783989?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:21","pubTimestamp":1774880480,"startTime":"0","endTime":"0","summary":"泰凌医药集团最新披露，其全年预计亏损额较此前发布的业绩指引进一步收窄，减少金额达1540万港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01011","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126497291","title":"泰凌医药：配发发行逾2.74亿股，约占已发行股本40.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126497291","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126497291?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:36","pubTimestamp":1774438587,"startTime":"0","endTime":"0","summary":"中国泰凌医药集团有限公司（股票代码：01011）于2026年3月25日发布公告，宣布配发及发行274,751,679股代价股份。本次发行获股东特别大会于2026年1月15日批准，所涉股份于3月25日完成配发。\n\\n\\n根据公告披露，本次发行股份数约占发行前已发行股本的40.75%，发行价格为每股0.45港元。发行完成后，公司已发行股本由674,246,015股增至948,997,694股，库藏股数量不变。\n\\n\\n公司在公告中确认，本次股份发行已履行相关上市规则与法律法规要求，并获得董事会正式授权批准。该公告由执行董事吴铁签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622002020","title":"泰凌医药(01011)完成收购浙江康源医疗器械58.11%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2622002020","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622002020?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:21","pubTimestamp":1774437695,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰凌医药 发布公告，就有关公司拟约1.16亿元收购浙江康源医疗器械58.11%股权的相关事宜。公司已于2026年3月25日按每股代价股份0.45港元的发行价向8名卖方发行及配发2.75亿股新股份以完成支付代价，通函“先决条件”分节所载买卖协议及补充协议的所有先决条件已获达成。收购事项完成后，公司透过全资附属公司间接持有浙江康源医疗器械有限公司58.11%股权，其财务业绩将于集团账目内综合入账。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418900.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1100","BK1574","159883","09997","BK1222","BK1583","01011","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614401757","title":"泰凌医药(01011)发盈警 预期2025年股东应占亏损净额约2500万元至3000万元 同比减少约43.8%至53.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614401757","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614401757?lang=zh_cn&edition=full","pubTime":"2026-02-26 18:52","pubTimestamp":1772103162,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰凌医药(01011)发布公告，预期本集团于截至2025年12月31日止年度(本年度)将取得本公司拥有人应占亏损净额介乎约人民币2500万元至人民币3000万元，较截至2024年12月31日止年度(上一年度)取得的本公司拥有人应占亏损净额约人民币5340万元，显著减少约43.8%至53.2%。预期亏损减少主要归因于以下因素：上一年度因会计重分类而确认的围绕北京康辰生物科技有限公司股权的一次性非现金公允价值亏损约人民币2950万元，于本年度不再出现;及按公允值计入损益的金融资产(即上述股权)于本年度取得约人民币1400万元的公允价值收益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614052252","title":"泰凌医药盘中异动 急速拉升7.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614052252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614052252?lang=zh_cn&edition=full","pubTime":"2026-02-25 10:11","pubTimestamp":1771985470,"startTime":"0","endTime":"0","summary":"2026年02月25日早盘10时11分，泰凌医药股票出现异动，股价快速上涨7.79%。截至发稿，该股报0.830港元/股，成交量0股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。泰凌医药股票所在的药品行业中，整体涨幅为0.44%。其相关个股中，泰凌医药、中国医疗集团、联邦制药涨幅较大，振幅较大的相关个股有中国医疗集团、长风药业、英硅智能，振幅分别为10.29%、6.17%、5.80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225101110a4c51f27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225101110a4c51f27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613751174","title":"泰凌医药02月23日主力净流入128.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2613751174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613751174?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:15","pubTimestamp":1771834534,"startTime":"0","endTime":"0","summary":"02月23日, 泰凌医药股价涨2.67%，报收0.77元，成交金额191.5万元，换手率0.37%，振幅5.33%，量比50.38。泰凌医药今日主力资金净流入128.6万元，上一交易日主力净流出0万元。该股主力净额占比0.25%，港股市场排名21/2717。|02月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|烯石电车新材料|2.62%|#|力天影业|1.76%|#|浙江世宝|0.90%|#|...|...|#21|泰凌医药|0.25%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161715a71558af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223161715a71558af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610336693","title":"泰凌医药(01011)2月10日起短暂停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2610336693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610336693?lang=zh_cn&edition=full","pubTime":"2026-02-10 09:16","pubTimestamp":1770686214,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰凌医药(01011)发布公告，公司股份已于2026年2月10日上午9时03分起短暂停止买卖。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01011","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610566250","title":"泰凌医药(01011)拟发行本金总额6500万港元可换股债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2610566250","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610566250?lang=zh_cn&edition=full","pubTime":"2026-02-10 07:11","pubTimestamp":1770678687,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰凌医药 发布公告，于2026年2月9日，公司与认购人订立认购协议，据此，认购人已有条件同意认购，而本公司已有条件同意发行本金总额为6500万港元的2028年到期的两年期无抵押5%计息可换股债券。发行债券的所得款项总额及所得款项净额将分别约为6500万港元及6400万港元。于本公告日期，公司已发行股份合共6.74亿股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609304915","title":"泰凌医药股价拉升12.33% 市值涨6817.01万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609304915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609304915?lang=zh_cn&edition=full","pubTime":"2026-02-05 14:15","pubTimestamp":1770272139,"startTime":"0","endTime":"0","summary":"2026年02月05日下午盘14时15分，泰凌医药股票出现异动，股价急速拉升12.33%。截至发稿，该股报0.820港元/股，成交量13.01万股，换手率0.02%，振幅10.96%。资金方面，该股资金流入8.24万港元，流出1.48万港元。泰凌医药股票所在的药品行业中，整体跌幅为0.05%。其相关个股中，联邦制药、九源基因、四环医药涨幅较大，振幅较大的相关个股有精优药业、德琪医药-B、泰德医药，振幅分别为25.61%、18.57%、13.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205141539a47ed5e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205141539a47ed5e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01011","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602349913","title":"泰凌医药盘中异动 快速下挫5.68%报0.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602349913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602349913?lang=zh_cn&edition=full","pubTime":"2026-01-09 10:44","pubTimestamp":1767926689,"startTime":"0","endTime":"0","summary":"2026年01月09日早盘10时44分，泰凌医药股票出现波动，股价快速下挫5.68%。截至发稿，该股报0.830港元/股，成交量17万股，换手率0.03%，振幅3.41%。资金方面，该股资金流入0港元，流出14.5万港元。泰凌医药股票所在的药品行业中，整体跌幅为0.30%。其相关个股中，劲方医药-B、绿叶制药、开拓药业-B涨幅较大，振幅较大的相关个股有劲方医药-B、中智药业、励晶太平洋，振幅分别为12.38%、10.84%、5.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010910444997a14c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010910444997a14c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01011","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601457348","title":"泰凌医药盘中异动 股价大涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601457348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601457348?lang=zh_cn&edition=full","pubTime":"2026-01-06 09:55","pubTimestamp":1767664559,"startTime":"0","endTime":"0","summary":"2026年01月06日早盘09时55分，泰凌医药股票出现异动，股价大幅拉升6.10%。截至发稿，该股报0.870港元/股，成交量10000股，换手率0.00%，振幅0.00%。泰凌医药股票所在的药品行业中，整体跌幅为0.05%。其相关个股中，中智药业、泰凌医药、九源基因涨幅较大，振幅较大的相关个股有中智药业、励晶太平洋、英硅智能，振幅分别为17.95%、6.00%、4.01%。泰凌医药公司简介：中国泰凌医药集团有限公司是一家主要提供医药产品销售及分销服务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106095559a6f80fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106095559a6f80fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01011","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600707996","title":"泰凌医药盘中异动 临近午盘大幅下跌7.87%报0.820港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600707996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600707996?lang=zh_cn&edition=full","pubTime":"2025-12-31 11:32","pubTimestamp":1767151952,"startTime":"0","endTime":"0","summary":"2025年12月31日临近午盘11时32分，泰凌医药股票出现异动，股价急速下挫7.87%。截至发稿，该股报0.820港元/股，成交量40万股，换手率0.06%，振幅11.24%。资金方面，该股资金流入3.67万港元，流出22.22万港元。泰凌医药股票所在的药品行业中，整体跌幅为0.22%。其相关个股中，英硅智能、海王英特龙、劲方医药-B涨幅较大，振幅较大的相关个股有英硅智能、中智药业、海王英特龙，振幅分别为24.08%、7.41%、7.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231113232a6e3c1a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231113232a6e3c1a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595789790","title":"泰凌医药12月29日主力净流出25.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2595789790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595789790?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996115,"startTime":"0","endTime":"0","summary":"12月29日, 泰凌医药股价跌5.38%，报收0.88元，成交金额172.0万元，换手率0.26%，振幅12.90%，量比3.47。泰凌医药今日主力资金净流出25.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨8.64%，主力资金累计净流出25.0万元；近20日主力资金累计净流出25.0万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161602a6dc3352&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161602a6dc3352&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01011"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ntpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1096},{"period":"3month","weight":-0.1667},{"period":"6month","weight":-0.1667},{"period":"1year","weight":0.4607},{"period":"ytd","weight":-0.2073}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国泰凌医药集团有限公司是一家主要提供医药产品销售及分销服务的投资控股公司。该公司通过两个分部运营业务。数字服务分部主要提供与骨健康知识的市场推广及宣传有关的数字服务。销售代理分部主要提供代理服务为代理客户向外部客户销售医疗及健康相关产品服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.003177},{"month":2,"riseRate":0.466667,"avgChangeRate":0.045108},{"month":3,"riseRate":0.4,"avgChangeRate":-0.034671},{"month":4,"riseRate":0.6,"avgChangeRate":0.215361},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.024773},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.008832},{"month":7,"riseRate":0.4,"avgChangeRate":-0.01165},{"month":8,"riseRate":0.266667,"avgChangeRate":-0.075011},{"month":9,"riseRate":0.4,"avgChangeRate":0.038353},{"month":10,"riseRate":0.4,"avgChangeRate":-0.009707},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.071764},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.020063}],"exchange":"SEHK","name":"泰凌医药","nameEN":"NT PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰凌医药(01011)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰凌医药(01011)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰凌医药,01011,泰凌医药股票,泰凌医药股票老虎,泰凌医药股票老虎国际,泰凌医药行情,泰凌医药股票行情,泰凌医药股价,泰凌医药股市,泰凌医药股票价格,泰凌医药股票交易,泰凌医药股票购买,泰凌医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰凌医药(01011)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰凌医药(01011)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}